Mortality in CABG: What's Next?
Over the past 48 years, coronary artery bypass grafting (CABG) has been among the most studied procedure in all of medicine. In part this has been because CABG is a high-volume, high-cost intervention for ischemic heart disease. But in addition CABG is associated with an easily identifiable outcome that occurs with sufficient frequency to be of substantial interest to both providers and patients, namely procedural mortality. The initial link between CABG and mortality was from the left main subset of the CASS trial, which interestingly only included 150 patients1. (SELECT FULL TEXT TO CONTINUE)
- Received April 16, 2012.
- Accepted April 18, 2012.
- Copyright © 2012, American Heart Association, Inc. All rights reserved. Unauthorized use prohibited